IGLV3-21R110-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemia.
Fischer C, Chen SS, Nimmerfroh J, Eugster A, Stücheli S, Schultheiß C, Widmer C, Heim D, Kasenda B, Passweg J, Kobold S, Egli L, Coianiz N, Chijioke O, Chiorazzi N, Follo M, Läubli H, Peipp M, Binder M.
Fischer C, et al. Among authors: chen ss.
Haematologica. 2025 Sep 11. doi: 10.3324/haematol.2025.287697. Online ahead of print.
Haematologica. 2025.
PMID: 40931870
Free article.